Lab Vision Corporation

Product code: MS-230-P; lot 230P1409A, Expiry 9-2016; Product code: MS-230-P0; lot 230P1409C, Expiry 9-2016.

Hematology and Pathology Devices

1

No

Worldwide Distribution: US distribution to states of: CA and WA, and countries of: Serbia, Germany and Netherlands.

Thermo Scientific p21 WF1 Ab-3 (DCS-60.2) || 1 ml (0.4mg/ml): || Product code: MS-230-P and MS-230P0; || Hematology: p21WAF1/Cip1/Sdi1/Pic1 is a tumor suppressor protein. Expression of p21WAF1 is induced by wild type, but not mutant, p53 suppressor protein. The p21WAF1 protein binds to cyclin/CDK complexes and inhibits their kinase activity thereby stopping cell cycle progression. It also binds to PCNA (proliferating cell nuclear antigen) and blocks DNA replication but not the DNA repair process. || Product is intended for qualitative immunohistochemistry with normal and neoplastic formalin-fixed, paraffin-embedded tissue sections, to be viewed by light microscopy.

PN/ MS-354-P0, LN 354P1206K; Expiration 03/2015.

Hematology and Pathology Devices

1

No

Worldwide Distribution: US (nationwide) including the states of TX and MA and internationally to: Turkey.

Estrogen Receptor AB-11 (Clone ID5) || Mouse Monoclonal Antibody || 1 mk (2mg.ml) Manufactured by: Lab Vision Corporation, Fremont, CA || Thermo Fisher Scientific || Anatomical Pathology || Tudor Rd., Manor Park || Rancorn, Cheshire WA7 1TA UK || Analyte specific reagent. It is intended for qualitative immunohistochemistry with normal and neoplastic formalin-fixed, paraffin embedded tissue sections, to be viewed by light microscopy.

Product Code: RB-368-R7; RB368-R1, Lot Number 368R1407A 368R1407C 368R1407D 368R1407E, all with expiry dates of July 2016. Product code: RB368-R1, Lot Number 368R1407B.

Hematology and Pathology Devices

1

No

Worldwide Distribution - US including CA, NY, GA, MS, PA, MA, TX, KY, AZ. and Internationally to Greece, France, Germany, Singapore and Serbia.

CEA / CD66e Ab-2, Product code RB-368-R7, RB-368-R1; 7 ml each. || Description  Carcinoembryonic antigen (CEA), is synthesized during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is reportedly useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). || This product is intended for qualitative immunohistochemistry with normal and neoplastic formalin-fixed, paraffin-embedded tissue sections, to be viewed by light microscopy.